| Stage | SWKS | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $935M | 100.00% | $96.2B | 100.00% | NVDA ×102.93 |
| Gross profit | $375M | 40.12% | $72.1B | 74.98% | NVDA +34.9pp |
| Operating income | $49M | 5.19% | $63.7B | 66.24% | NVDA +61.0pp |
| Pre-tax income | $49M | 5.22% | $71.5B | 74.32% | NVDA +69.1pp |
| Net income | $34M | 3.63% | $59.7B | 62.03% | NVDA +58.4pp |
| Stage | SWKS | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $935M100.00% | $96.2B100.00% | NVDA ×102.93 |
| Gross profit | 40.12%$375M | 74.98%$72.1B | NVDA +34.9pp |
| Operating income | 5.19%$49M | 66.24%$63.7B | NVDA +61.0pp |
| Pre-tax income | 5.22%$49M | 74.32%$71.5B | NVDA +69.1pp |
| Net income |
| 3.63%$34M |
| 62.03%$59.7B |
| NVDA +58.4pp |
No shared counterparties.